On the recordMarch 9, 2015
This has led me to question whether CMS consults with the FDA and NIH in making its coverage decisions.
Source
congress.govThis has led me to question whether CMS consults with the FDA and NIH in making its coverage decisions.
Senator Collins expresses concern over CMS not consulting FDA and NIH on coverage decisions.
Share & report
More from Susan Collins
The administration's new budget seeks to eliminate what is truly a critical program.
I did not express concerns to the White House. I had some reservations, but I certainly had not reached a final judgment.